Demographic and clinical annotation of study cohort
| Variable . | Study participants (n = 84) . | Donors (n = 42) . | Recipients (n = 42) . |
|---|---|---|---|
| Patient-related variables | |||
| Age (y), median (range) | |||
| At transplantation / donation | 38 (15-65) | 37 (15-65) | 39 (16-58) |
| At study inclusion | 59 (29-95) | 57 (29-95) | 61 (32-77) |
| Time since transplantation (y), median (range) | 16 (10-32) | ||
| Gender | |||
| Male | 45 | 22 | 23 |
| Female | 39 | 20 | 19 |
| Disease | |||
| AML | 17 | ||
| MDS | 1 | ||
| CML | 6 | ||
| ALL | 8 | ||
| NHL | 3 | ||
| MM | 2 | ||
| SAA | 2 | ||
| Nonmalignant | 3 | ||
| Transplantation-related variable | |||
| Graft type | |||
| PBSCs | 14 | ||
| BM | 28 |
| Variable . | Study participants (n = 84) . | Donors (n = 42) . | Recipients (n = 42) . |
|---|---|---|---|
| Patient-related variables | |||
| Age (y), median (range) | |||
| At transplantation / donation | 38 (15-65) | 37 (15-65) | 39 (16-58) |
| At study inclusion | 59 (29-95) | 57 (29-95) | 61 (32-77) |
| Time since transplantation (y), median (range) | 16 (10-32) | ||
| Gender | |||
| Male | 45 | 22 | 23 |
| Female | 39 | 20 | 19 |
| Disease | |||
| AML | 17 | ||
| MDS | 1 | ||
| CML | 6 | ||
| ALL | 8 | ||
| NHL | 3 | ||
| MM | 2 | ||
| SAA | 2 | ||
| Nonmalignant | 3 | ||
| Transplantation-related variable | |||
| Graft type | |||
| PBSCs | 14 | ||
| BM | 28 |
AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CML, chronic myeloid leukemia; MDS, myelodysplastic syndrome; MM, multiple myeloma; NHL, non-Hodgkin lymphoma; PBSCs, peripheral blood stem cells; SAA, severe aplastic anemia.